Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease

Conclusion: The treatment with pemetrexed plus platinum has a high risk of AE-ILD in patients with advanced nonsquamous NSCLC and preexisting ILD.

Source: In Vivo - October 28, 2019 Category: Research Authors: FUJITA, T., KUROKI, T., HAYAMA, N., SHIRAISHI, Y., AMANO, H., NAKAMURA, M., HIRANO, S., TABETA, H., NAKAMURA, S. Tags: Clinical Studies Source Type: research